Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
✍ Scribed by Bidard, François-Clément; Peeters, Dieter J; Fehm, Tanja; Nolé, Franco; Gisbert-Criado, Rafael; Mavroudis, Dimitrios; Grisanti, Salvatore; Generali, Daniele; Garcia-Saenz, Jose A; Stebbing, Justin; Caldas, Carlos; Gazzaniga, Paola; Manso, Luis; Zamarchi, Rita; de Lascoiti, Angela Fernandez; De Mattos-Arruda, Leticia; Ignatiadis, Michail; Lebofsky, Ronald; van Laere, Steven J; Meier-Stiegen, Franziska; Sandri, Maria-Teresa; Vidal-Martinez, Jose; Politaki, Eleni; Consoli, Francesca; Bottini, Alberto; Diaz-Rubio, Eduardo; Krell, Jonathan; Dawson, Sarah-Jane; Raimondi, Cristina; Rutten, Annemie; Janni, Wolfgang; Munzone, Elisabetta; Carañana, Vicente; Agelaki, Sofia; Almici, Camillo; Dirix, Luc; Solomayer, Erich-Franz; Zorzino, Laura; Johannes, Helene; Reis-Filho, Jorge S; Pantel, Klaus; Pierga, Jean-Yves; Michiels, Stefan
- Book ID
- 121528185
- Publisher
- The Lancet
- Year
- 2014
- Tongue
- English
- Weight
- 377 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Serum circulating immune complexes (CIC) were repeatedly measured by means of the Cl binding assay (Cba) and the Raji cell assay (Rca) in 158 patients with metastatic breast cancer (mbc). Frequency of occurrence and levels of CIC were only slightly increased in mbc when compared to age‐